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Abstract: Cyclin dependent kinase inhibitor 1c (Cdkn1c) is a maternally expressed imprinted gene
with roles in embryonic development, post-natal metabolism and behaviour. Using mouse models
with altered dosages of Cdkn1c, we have previously identified a role for the gene in promoting
brown adipose tissue formation. Here, we use these transgenic mouse lines to model the loss of
imprinting of Cdkn1c in adulthood. We demonstrate that only a two-fold increase in the expression
of Cdkn1c during development is sufficient to protect against age-related weight gain in addition
to glucose and insulin intolerance. Further to this, we show that the loss of imprinting of Cdkn1c
protects against diet-induced obesity. Bisulphite sequencing was performed to test the stability of the
two differentially methylated regions that regulate Cdkn1c imprinting, and both were found to be
unaltered in aged or diet-challenged adipose tissue, despite drastic reductions in Cdkn1c expression.
These data demonstrate a critical role for Cdkn1c in regulating adult adipose tissue, with modest
changes in expression capable of protecting against both age and diet-induced obesity and metabolic
syndrome, with a natural decline in Cdkn1c expression observed that may contribute to less healthy
metabolic aging. Finally, we have observed a post-natal insensitivity of the imprint to environmental
factors, in contrast to recent observations of an in utero sensitivity.
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1. Introduction
Genomic imprinting is a phenomenon of epigenetic gene regulation, whereby mono-allelic
expression of a gene occurs, in a parent-of-origin specific manner in placental mammals and some
plants [1,2]. Cyclin dependent kinase inhibitor 1c (Cdkn1c) is a maternally expressed imprinted gene
found on the IC2 imprinting cluster on mouse chromosome 7 [3]. The gene functions both in
limiting cell proliferation, primarily as a G1/S phase inhibitor [4,5], and in directing differentiation of
certain select lineages. These include regulating the differentiation of skeletal muscle [6], amacrine
cells in the retina [7], and the maintenance of adult quiescent neural stem cell populations [8,9].
Imprinted expression of Cdkn1c is achieved through two distinct differentially methylated regions
(DMRs). A germline differentially methylated region termed KvDMR is located >200 kb upstream of
Cdkn1c within the Kcnq1 gene, and this region acquires DNA methylation in the maternal germline
in mice and humans to establish imprinted expression of an extensive genomic region on mouse
distal chromosome 7/human chromosome 11p15, called the IC2 cluster [10–12]. The Cdkn1c somatic
DMR (sDMR) is located at the 5′ terminus of the Cdkn1c coding region, and is required for silencing
maintenance, as opposed to establishment, through methylation of the silent paternally inherited
allele [13]. This region has been shown to only possess methylation in somatic tissue in vivo, acquired
during early embryonic development and after allelic expression is established [14–16]. Our recent
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work using an imaging-based model of Cdkn1c expression reported that the Cdkn1c sDMR is sensitive
to gestational protein restriction, with offspring exposed to the diet found to have reduced embryonic
and post-natal methylation at this region, with an accompanying loss of imprinting of Cdkn1c [17].
Elevated expression of Cdkn1c has been implicated as a cause of two similar but distinct childhood
growth restriction disorders, Silver–Russell (SRS) and IMAGe syndrome [18], while a loss-of-function
of Cdkn1c is present in familial cases of the childhood overgrowth disorder Beckwith–Wiedemann
syndrome [19]. In order to model SRS, our lab developed transgenic mouse lines carrying additional
copies of Cdkn1c, on a bacterial artificial chromosome (BAC) spanning Cdkn1c and two other imprinted
genes Phlda2 and Slc22a18. To distinguish between the effects of elevated Cdkn1c expression and the
effect of increasing the dosage of the other two genes, we developed a transgenic line containing
a modified version of this same BAC where Cdkn1c expression is disrupted by a β-galactosidase
insertion [20,21]. These lines provide an alternative route for studying imprinted genes, focusing on
dosage rather than gene function per se. Classical knockout models, used to study the gene function of
imprinted genes, frequently present with high levels of lethality associated with heterozygous deletion
models presenting as a phenotypic homozygous deletion, due to the mono-allelic expression [22].
Using the BAC transgenic lines, we have demonstrated a dosage-dependent fetal growth restriction
due to elevated Cdkn1c [20], which was maintained post-natally and into early adulthood. Further to
this, a new function of the gene in regulating brown adipose tissue formation was recently described
by our group, with elevated markers of mitochondrial uncoupling also uncovered in the white
adipose tissue [23]. In SRS, children are born small and fail to catch up, with excessive thinness
being an additional characteristic. Some SRS children are also reported to be fussy eaters, which has
been suggested to contribute to their failure to gain weight. However, we showed that young mice
carrying an extra copy of Cdkn1c were also thin with little subcutaneous fat despite consuming similar
calories to controls [23]. Some SRS children also have night sweats which could suggest dysfunctional
thermoregulation, consistent with the increase in brown adipose tissue we observed in our mouse
model [23].
In this study, we further explored the impact of increased Cdkn1c dosage in adult mice, focusing on
the predicted role for Cdkn1c in influencing adult weight gain through regulating the development of
brown fat depots. Imprinted gene function has classically been thought to be predominantly restricted
to regulating embryonic and placental development; however, recent work has highlighted important
post-natal functions for this class of gene [23–25]. Therefore, further elucidation of both gene and
imprint function, in adulthood, will enable a clearer understanding of this method of epigenetic
gene regulation.
2. Results
We have previously reported that mice bearing one (Cdkn1cBACx1) or two copies (Cdkn1cBACx2)
of a BAC spanning the Cdkn1c locus were significantly lighter than wild type (WT) litter mates at
10 weeks of age, with relative increases in expression of Cdkn1c in white and brown adipose tissue [23].
This phenotype was attributed to excess Cdkn1c, causing jointly a fetal growth restriction phenotype
that was not resolved post-natally and reduced white adipose tissue (WAT) stores due to elevated
brown adipose tissue (BAT) formation. To further understand the effect of elevated Cdkn1c into
adulthood, mice were aged to 1 year, co-housed with sex-matched WT littermates. Monthly weighing
found significantly reduced weights in both male (Figure 1a) and female (Figure 1b) Cdkn1cBACx1
(light green) and Cdkn1cBACx2 (dark green) mice when compared to wild type (black). In fact, all four
transgenic groups increased in weight by less than 3 g over this 6-month period, in contrast to
an average 7.5 g increase in male, and 4.5 g increase in female WT. Glucose and insulin tolerance testing
was performed on the male cohort at 1 year of age, and found a significantly improved clearance
of glucose after challenge (Figure 1c) in both Cdkn1cBACx1 and Cdkn1cBACx2 lines, in addition to
heightened response to insulin testing, compared to age-matched WT males (Figure 1d). White adipose
deposits were weighed in culled mice and found to be significantly smaller in both males (Figure 1e)
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and females (Figure 1f), as a percentage of total body weight, in order to control for growth restriction.
As had been observed in the whole-body weights (Figure 1a,b), this reduction was found to be
dosage-dependent, with Cdkn1cBACx2 mice showing a greater reduction in fat pad weights when
compared to Cdkn1cBACx1.
Following the observation that elevated Cdkn1c could protect against age-related metabolic
syndrome, we challenged Cdkn1cBACx1 male mice and litter-matched WT controls with a high fat
diet (58V8, TestDiet) from 10 weeks of age for 12 weeks. Cdkn1cBACx1 males were found to be
highly resistant to weight gain during the dietary challenge (Figure 2a). The average weight gain was
12.4% of the original body weight (2.1 g) over the 12-week period in contrast to the average 41.2%
(10.1 g) gained by wild type male controls. In this experiment, we also included a third transgenic
line to isolate the contribution of Cdkn1c to this resistance against weight gain. This third line of mice
called Cdkn1cBAC-LacZ carries one copy of the same BAC transgene but without over-expression of
Cdkn1c. Any phenotypes observed in Cdkn1cBACx1 mice and Cdkn1cBACx2 mice that are absent in
Cdkn1cBAC-LacZ mice must be due to elevated Cdkn1c. Cdkn1cBAC-LacZ male mice gained weight on
the high fat diet with the same profile as WT controls (Figure 2b) demonstrating that this protection
against weight gain was due to Cdkn1c alone. To explore the extent of this phenotype, glucose tolerance
testing was performed on these animals, with Cdkn1cBACx1 males displaying significantly improved
glucose clearance (Figure 2c), compared to wild type mice. Further to this, insulin tolerance testing
revealed a heightened response to insulin challenge in Cdkn1cBACx1 males (Figure 2d), correlating
with the effects observed in aging animals (Figure 1c,d).
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Figure 1. Increased Cdkn1c dosage protects against age-related metabolic disorder. (a) Adult
whole-body weights. Both Cdkn1cBACx1 (single copy bacterial artificial chromosome (BAC), light green)
and Cdkn1cBACx2 (double copy, dark green) transgenic males were significantly lighter than wild type
(black) litter mates between 6 months and 1 year of age, in a dosage-dependent manner. Individual
12-month weights are displayed on the right-hand graph (n: WT 8, Cdkn1cBACx1 6, Cdkn1cBACx2 4),
* p < 0.05, ** p < 0.01; (b) Cdkn1cBACx1 (light green) and Cdkn1cBACx2 (dark green) transgenic females
were also found to be significantly lighter than wild type (black) litter mates between 6 months and
1 year of age. Individual 12-month weights are displayed on the right-hand graph (n: 9, 5, 4), * p < 0.05,
** p < 0.01; (c) Glucose tolerance testing of 1-year old males revealed an improved clearance of glucose
challenge in both Cdkn1cBACx1 and Cdkn1cBACx2 lines when compared to wild type mice. (n: 8, 6, 4),
* p < 0.05, ˆ p < 0.05 (Cdkn1cBACx2 only); (d) Insulin tolerance testing of 1-year old males revealed
greater sensitivity to insulin in both Cdkn1cBACx1 and Cdkn1cBACx2 lines when compared to wild type
mice, (n: 8, 6, 4), * p < 0.05; (e) Wet weight of white adipose tissue in 1-year old males, as a percentage
of total body weight. Mesenteric (M), epididymal (E) and retroperitoneal (R) depots were all found to
be significantly smaller in Cdkn1cBACx1 and Cdkn1cBACx2 males compared to wild type. (n: 8, 6, 4),
* p < 0.05, ** p < 0.01, *** p < 0.001; (f) Wet weight of white adipose tissue in 1-year old females,
as a percentage of total body weight. Mesenteric (M), peri-ovarian (P) and retroperitoneal (R) depots
were all found to be significantly smaller in Cdkn1cBACx1 and Cdkn1cBACx2 males compared to wild
type, in a dosage-dependent manner. (n: 9, 5, 4). * p < 0.05, ** p < 0.01, *** p < 0.001.
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(light green) were found to resist weight gain during a 12-week high fat diet challenge, while wild 
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Figure 2. Increased Cdkn1c dosage protects against diet-induced obesity. (a) Cdkn1cBACx1 male
mice (light green) were found to resist weight gain during a 12-week high fat diet challenge, while
wild type (WT) (black) and Cdkn1cBAC-LacZ (grey—no elevated Cdkn1c expression) progressively
increased in weight and were not significantly different from one another (n: WT 9, Cdkn1cBACx1 8,
Cdkn1cBAC-LacZ 10), ** p < 0.01, *** p < 0.001; (b) the food consu ption difference bet een T,
Cdkn1cBACx1 and Cdkn1cBAC-LacZ males on a high-fat diet was not found to be significantly different,
(n: 7, 5, 8); (c) lucose tolerance testing of adult ale ice c pleting a i -fat iet c allenge.
Cdkn1cBACx1 (light gre n) males were found to possess significantl i r l c s cl r c
compared to WT (black), (n: 9, 8), * p < 0.05; (d) Insulin tolerance testing of adult male mice completing
a high-fat diet challenge. Cdkn1cBACx1 (light green) males were found to possess significantly greater
sensitivity to insulin challenge between 30–60 min post injection, (n: 9, 8), * p < 0.05.
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Reduced weight in adult mice possessing excess Cdkn1c may, in part,2 be attributed to increased
brown adipose tissue content, both in the classic interscapular brown adipose depot but also within
white adipose depots, and therefore elevated mitochondrial uncoupling [23]. In order to assess whether
the protective phenotype observed in Cdkn1cBACx1 mice challenged with a high-fat diet could be
attributed to increased BAT content, core temperature was first checked after the 12-week dietary
challenge. Cdkn1cBACx1 males were found to be significantly hotter than wild type mice (Figure 3a).
Upon culling, the wet weights of selected white adipose depots were found to be significantly reduced
in the Cdkn1cBACx1 mice (Figure 3b), with epididymal (E) and retroperitoneal (R) depots more than
50% smaller than wild type, as a percentage of total body weight. Qualitatively, hematoxylin and
eosin (H+E) staining revealed differences in white adipocytes (Figure 3c) with WT epididymal and
anterior sub-cutaneous depots containing predominantly larger uni-locular adipocytes relative to the
corresponding depots from Cdkn1cBACx1 males, which contained areas of multi-locular adipocytes
most closely associated with brown adipocytes. In the liver, there appeared to be reduced lipid
accumulation (white regions) in Cdkn1cBACx1 compared to WT samples. We previously reported the
increased expression of a number of BAT markers downstream of the BAT-determining gene Prdm16
in WAT from young mice, and increased PRDM16 protein but not mRNA, suggesting a function for
Cdkn1c in the post-transcriptional regulation of Prdm16 [23]. QRT-PCR analysis of retroperitoneal
adipose tissue revealed a higher mRNA expression of mitochondrial uncoupling protein 1 (Ucp-1) and the
brown adipose markers PGC-1α, Cidea and Elovl3 in Cdkn1cBACx1 retroperitoneal depots relative to WT
(Figure 3d). While we have not excluded the contribution of other sites of Cdkn1c over-expression to
the phenotype, taken together, these results are consistent with the increased BAT driven by elevated
Cdkn1c dosage providing a protective effect against weight gain.
Recent work has shown that the epigenetic marks which silence the paternal allele of Cdkn1c
can be disrupted through protein restriction during gestation [17]. Further to this, the stability of
imprints during aging has recently come into focus, with several reports of altered DNA methylation
in aged samples [26,27]. We examined Cdkn1c expression in retroperitoneal white adipose tissue
(R) and interscapular brown adipose tissue (iBAT) in 10-week old WT mice compared to 12-month
old mice from the same colony. Older mice showed significantly reduced expression of Cdkn1c in
white adipose and slightly elevated expression in brown adipose tissue compared to younger mice
(Figure 4a). Two regions of differential methylation (Cdkn1c sDMR and KvDMR) that regulate Cdkn1c
expression were examined through bisulphite sequencing of genomic DNA from the same individuals
to try and account for these observed changes in transcription. Methylation of the Cdkn1c sDMR and
KvDMR in early life adipose tissue has previously been shown to be similar to that seen in other
tissue [23]. A qualitative analysis of 10-week (left column) and 1-year old (right column) wild type
retroperitoneal adipose tissue revealed a similar pattern of methylation at both Cdkn1c sDMR and
the KvDMR (Figure 4b). No gross differences were observed in brown adipose tissue (Figure 4c),
where expression had been found to be modestly elevated in 1-year old samples (Figure 4a). Finally,
samples were analyzed from the high-fat diet cohort, with no gross differences in methylation detected
after 12 weeks of dietary challenge in retroperitoneal tissue (Figure 4d).
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Figure 3. Cdkn1cBACx1 mice show reduced lipid stores and elevated brown adipose tissue (BAT)
markers in high-fat diet (HFD)-exposed white adipose tissue. (a) Rectal temperature of adult male mice
exposed to high-fat diet challenge. Cdkn1cBACx1 males (light green) had a significantly increased core
body temperature when compared to WT littermates (black), (n: 9, 8), ** p < 0.01; (b) Wet weight of white
adipose tissue in high-fat diet exposed males, as a percentage of total body weight. Mesenteric (M),
epididymal (E) and retroperitoneal (R) depots were all found to be significantly smaller in Cdkn1cBACx1
males (light green) than WT (black). (n: 9, 8), ** p < 0.01, *** p < 0.001; (c) H+E staining of epididymal
(top row), anterior sub-cutaneous (Sub Cut, middle row) white adipose and liver (bottom row) in
WT (left column) and Cdkn1cBACx1 (right column) adult males exposed to high-fat diet challenge.
Large unilocular cells were consistently observed in WT adipose depots, with lipid deposits clearly
visible in liver sections. Smaller unilocular and multi-locular adipocytes were observed in Cdkn1cBACx1
sections, with sparse lipid deposits in liver sections (scale bar: 20 µm); (d) Quantitative RT-PCR analysis
of brown adipose markers in retroperitoneal white adipose tissue, from adult male mice exposed to
a high-fat diet. Significantly elevated markers of brown adipogenesis were detected in Cdkn1cBACx1
transcripts when compared to wild type (n: 4, 4). ** p < 0.01.
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Figure 4. The Cdkn1c imprint is stabl uring agi g and during post-natal diet challenge.
(a) Quantitative RT-PCR analysis of Cdkn1c expression changes between 10 weeks and 1 year of age in
WT adipose depots. A significantly reduced expression of Cdkn1c was detected in aged retroperitoneal
(R) adipose tissue, while brown adipose (iBAT) depots were found to possess small but significant
increases in Cdkn1c expression in aged tissue, (n: 4, 4), * p < 0.05, ** p < 0.01; (b) Representative bisulphite
sequencing analysis of Cdkn1c sDMR and KvDMR 10-week (left column) and 1-year old (right column)
retroperitoneal (R) adipose tissue found similar patterns of methylation between timepoints in male
mice (n: 2, 2) (Filled circles: Methylated CpG, Unfilled circles: Un-methylated CpG); (c) Representative
bisulphite sequencing analysis of Cdkn1c sDMR and KvDMR in 10-week (left column) and 1-year old
(right column) iBAT found similar patterns of methylation between timepoints in male mice (n: 2, 2);
(d) Representative bisulphite sequencing analysis of Cdkn1c sDMR and KvDMR control (left column)
and high-fat diet fed (right column) retroperitoneal adipose tissue (R) methylation, from adult male
WT mice. Similar patterns of methylation were found between diets (n: 2, 2).
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3. Discussion
In this study, we show that mice with a single extra copy of Cdkn1c are able to resist both
age and diet-driven weight gain and maintain a healthier management of glucose than matched
controls. While we have not defined the mechanism underlying this phenotype, the gains in brown
adipose tissue that we have shown in younger mice [23], alongside the higher body temperature and
increased expression of markers of brown fat, suggest that increased thermogenesis may, at least in
part, play a contributory role.
Using both loss-of-expression and gain-in-expression animal models, alongside ex-vivo
approaches, we previously identified an important and intrinsic role for Cdkn1c in the development
of both classic brown adipose tissue and the brown-like adipose tissue that develops post-natally
within white adipose depots [23]. We showed that mice with a 2–3-fold elevated expression of Cdkn1c
possessed substantially more brown adipose tissue and substantially less white adipose tissues at
10 weeks of age. In this new study, we show that mice from these same transgenic lines do not
gain significant weight as they age, unlike their wild type littermates, and this was true for both
males and females. We also show that these older mice are better able to manage their glucose levels.
A caveat to this observation is the high blood glucose values relative to other studies on this strain
background [28]. This may be explained by the standard chow on which we routinely maintain mice,
Labdiet 5008, which provides a relatively higher proportion of energy from fat and carbohydrate
compared to other standard chow diets and may induce a diabetic state when fed over a prolonged
period. An alternative and potentially more interesting explanation is that the WT mice were inherently
stressed, a factor known to impact blood glucose levels [29]. Higher stress levels in the WT littermate
controls is suggested by our previous observation that male Cdkn1cBACx1 mice disrupt social stability
when co-housed with WT mice, resulting in an increased incidence of fighting and wounding within
these groups [30]. Further studies including single housing animals will be required to fully explore
these differences.
We further show that younger mice exposed to a high-fat diet for 12 weeks gain almost no weight
despite consuming a similar amount of HFD as their WT counterparts under the same protocol. As with
the older mice, the high-fat diet-exposed Cdkn1c transgenic mice were also better able to manage their
glucose levels than the controls. Using a control line of mice (Cdkn1cBAC-LacZ) which carried the same
BAC transgene but without over-expression of Cdkn1c, we were able to attribute this weight resistance
phenotype to elevated Cdkn1c. Taken together, these data highlight a previously unappreciated role for
Cdkn1c in weight regulation later in life, at least in mice. The loss or gain in function of CDKN1C in
humans is already implicated in the childhood growth disorders Beckwith-Wiedemann Syndrome,
IMAGe syndrome and SRS, recapitulated to some extent in animal models. This new data highlights
a role for Cdkn1c in regulating adiposity in the adult mouse. Quite remarkably, only a two-fold elevation
in expression of Cdkn1c was able to protect mice against both age and diet-induced weight gain.
It should be noted that the changes we observed were between 6 months and 1 year of age, which is
thought to represent middle age in mice. Our analyses did not extend to cover the full aging period.
It will be interesting to follow these mice for an extended period into old age to ask whether they
maintain this metabolic advantage, and whether they have an extended lifespan. Further to this, while
a reduction in body weight was observed in both genders, a dosage dependent phenotype was not so
clearly observed in females. Variation in the individual weights of the transgenic groups was larger at
12 months than those observed in male mice (Figure 1a,b). It will be important to explore this potential
difference between genders in a larger cohort over a longer time period.
The inflexibility of the Cdkn1c imprint to either aging or post-natal diet modification contrasts
with data seen from in utero exposure [17]. We found that erosion of the Cdkn1c sDMR occurred
in offspring exposed to gestational low protein diet, with these changes maintained post-natally.
Our current data would therefore lend support to the hypothesis that altering the dosage of Cdkn1c in
response to gestational environmental factors can be achieved, but once laid down, this methylation
is resistant to post-natal adjustment. However, we analyzed DNA methylation in a small number of
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individuals, so we cannot exclude more modest changes in DNA methylation with time or changes
in other tissues or other strains of mice not analyzed. This stubbornness to change likely provides
a protective effect in mice, as has been highlighted by the differences in weight observed in our loss
of imprinting model (Cdkn1cBACx1). A single extra copy of Cdkn1c was sufficient to restrict mice in
both aging and diet models to only modest weight gain, in addition to the embryonic and post-natal
growth restriction previously described [20]. In a laboratory setting, such responses would appear
advantageous. However, outside of food available ad libitum, such excessive uncoupling may in fact
reduce survival chances, due to the challenges in laying down sufficient adipose stores. By restricting
changes in imprinted status to an embryonic window, rather than a constant environmental sensitivity,
this might be prevented.
Cdkn1c has only recently been identified as having a role in adipose tissue development [23].
Interestingly, the response to glucose and insulin tolerance testing in aging mice was found to be
largely comparable between the Cdkn1cBACx1 and Cdkn1cBACx2 line, whereas whole body and adipose
depots weights were found to be dosage dependent, with the Cdkn1cBACx2 line having even greater
reductions. This dosage-based phenotype is also present at early post-natal and fetal time points [20].
The lack of a dosage-based phenotype for glucose and insulin tolerance may be attributed to simply
avoiding the age-related metabolic syndrome that is observed in wild type mice, due to their leanness,
rather than substantial changes to insulin signaling. However, epigenetic dysregulation at the IC2
cluster has previously been demonstrate to affect β-cell mass [31], and therefore a direct role cannot
be excluded.
In summary, this is the first report linking Cdkn1c dosage to weight gain in adult mice.
Our findings, if they translate to humans, have potentially monumental implications for human
health. In addition to the potential relevance to the rare human disorders that involve either elevated
expression of Cdkn1c or gain in function mutations of this gene, SRS and IMAGe syndrome [18],
worldwide obesity has nearly tripled in the last 40 years, resulting in over 650 million obese adults
and an estimated 41 million children under the age of 5 years being overweight or obese (WHO).
Unlike many other genes implicated in weight regulation, Cdkn1c is epigenetically regulated.
This suggests the possibility that epidrugs could be developed that activate the silent Cdkn1c allele
with therapeutic benefit. Cdkn1c encodes a cyclin-dependent kinase inhibitor and, while we have not
identified the molecular mechanism through which Cdkn1c drives the development of brown adipose,
it may be possible to develop designer drugs to mimic this activity. Ultimately, drugs aimed at Cdkn1c
may provide a way to increase BAT thermogenesis in adult humans to increase whole-body energy
expenditure and address the global epidemic of obesity.
4. Materials and Methods
4.1. Animals and Husbandry
All animal studies and breeding were approved by the University of Cardiff ethical committee
and performed under a UK Home Office project license (30/2600 from 4 November 2007 until
4 November 2013). Mice were housed on a 12 h light–dark cycle with lights coming on at 06.00 h
with a temperature range of 21 ± 2 ◦C with free access to tap water and standard chow (Labdiet 5008,
Labdiet, St. Louis, MO, USA). BAC transgenic lines Cdkn1cBACx1 (previously known as 5D3; single
copy of unmodified BAC), Cdkn1cBACx2 (previously known as 5A4; two copies of unmodified BAC)
and Cdkn1cBAC-LacZ (previously known as 10–10; single copy of modified BAC with no transgenic
elevation of Cdkn1c) were bred onto a C57BL/6J (BL6) background for >12 generations and genotyped
as described [21]. For aging studies, mice were group housed and weighed monthly. For feeding studies,
grouped male mice were transferred onto 58V8 diet (TestDiet, St. Louis, MO, USA) for 12 weeks,
with weights measured weekly. Core body temperatures of high fat diet mice were monitored with
a rectal probe (IN005A, Vet-Tech solution, Congleton, UK).
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4.2. Glucose Tolerance Testing
Mice were fasted overnight, with access to water. All subjects were individually housed for
the duration of the test, and were weighed before testing began. Tail blood was taken and glucose
concentration was recorded by Glucose 201+ meter (HemoCue, Ängelholm, Sweden). After samples
were taken, mice were injected intraperitoneally with 10 mM/ kg (1.8 mg/g) glucose (Sigma Aldrich,
St. Louis, MO, USA) and further readings were taken at 30, 60, 90 and 120 min post-injection.
All experiments were performed blind.
4.3. Insulin Tolerance Testing
Mice were individually housed with access to food and water. Tail blood was collected and glucose
concentration was recorded by Glucose 201+ meter (HemoCue, Ängelholm, Sweden). After samples
were taken, mice were injected intraperitoneally with 0.75 U/ kg insulin (Novo Nordisk Bagsvaerd,
Denmark) and further readings were taken at 15, 30, 45 and 60 min post-injection. All experiments
were performed blind.
4.4. DNA, RNA and H+E Staining Analysis
Genomic DNA was bisulphite treated using an EZ DNA Methylation Kit (Zymo Research,
Irvine, CA, USA). Sodium modification treatments were carried out in duplicate for each DNA
sample and at least three independent amplification experiments were performed for each
individual examined. The region spanning the Cdkn1c sDMR was amplified by PCR using
primers 5′-tgggtgtagagggtggatttagtta-3′ and 5′-cccacaaaaaccctaccccc-3′ and hemi-nested primer
5′-gtattgttaggattaggatttagttggtagtagtag-3’. For amplification of KvDMR, the following primers
were used 5′-taaggtgagtggttttaggat-3′ and 5′-aatcccccacacctaaattc-3′ and hemi-nested primer
5′-ccactataaacccacacata-3′. TaKaRa EpiTaq™ HS (Takara, Shiga, Japan) was used for PCR amplification
according to the manufacturer’s specifications. The PCR products were cloned into pGEM-T (Promega,
Madison, WI, USA) and an average of 20 clones per sample were sequenced using M13 reverse primer
and an automated ABI Prism 3130xl Genetic Analyzer (Applied Biosystems, Foster City, CA, USA)
as previously described [16]. Quantitative RT-PCR was performed in duplicate on four independent
samples as previously described [32]. Briefly, total RNA was prepared from tissues using RNA-Bee
(AmsBio, Abingdon, UK). cDNA was prepared using M-MuLV reverse transcriptase (Roche, Basel,
Switzerland) with random hexamers under the manufacturers conditions. Quantitative RT-PCR was
performed in duplicate on four independent samples using DyNAmo HS SYBR Green qPCR kit
(Finnzymes, New York, NY, USA) against the reference gene β-Actin, and detected using the Chromo
4 Four-Color Real Time detector (MJ Research, Reno, NV, USA). H+E staining was performed as
previously described [21]. At least three samples per experimental group were fixed overnight in
phosphate-buffered 4% paraformaldehyde, paraffin-embedded and 7 µm sections cut, prior to H&E
staining. Images are representative of each experimental group.
4.5. Primers for qRT-PCR
Cidea F: 5′-tggaaaagggacagaaatgg R: 5′-tctcgtacatcgtggctttg
PGC-1α F: 5′-tcatcacctaccgttacacctg R: 5′-caagcttctctgagcttccttc
Elovl3 F: 5′-ctgttgctcatcgttgttgg R: 5′-atctgactacggcgtcatcc
Cdkn1c F: 5′-agagaactgcgcaggagaac R: 5′-tctggccgttagcctctaaa
Ucp-1 F: 5′-ggcaaaaacagaaggattgc R: 5′-taagccggctgagatcttgt
β-Actin F: 5′-cctgtatgcctctggtcgta R: 5′-ccatctcctgctcgaagtct
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4.6. Statistical Analyses
Statistical significance (probability values) was determined using the Student’s t-test (two-tailed
distribution and two sample unequal variance). For quantitative RT-PCR analysis, the Mann-Whitney
test was performed on ∆Ct values between groups.
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